Abstract:The therapeutic properties of plants have been recognised since time immemorial. Many pathological conditions have been treated using plant-derived medicines. These medicines are used as concoctions or concentrated plant extracts without isolation of active compounds. Modern medicine however, requires the isolation and purification of one or two active compounds. There are however a lot of global health challenges with diseases such as cancer, degenerative diseases, HIV/AIDS and diabetes, of which modern medicine is struggling to provide cures. Many times the isolation of "active compound" has made the compound ineffective. Drug discovery is a multidimensional problem requiring several parameters of both natural and synthetic compounds such as safety, pharmacokinetics and efficacy to be evaluated during drug candidate selection. The advent of latest technologies that enhance drug design hypotheses such as Artificial Intelligence, the use of 'organ-on chip' and microfluidics technologies, means that automation has become part of drug discovery. This has resulted in increased speed in drug discovery and evaluation of the safety, pharmacokinetics and efficacy of candidate compounds whilst allowing novel ways of drug design and synthesis based on natural compounds. Recent advances in analytical and computational techniques have opened new avenues to process complex natural products and to use their structures to derive new and innovative drugs. Indeed, we are in the era of computational molecular design, as applied to natural products. Predictive computational softwares have contributed to the discovery of molecular targets of natural products and their derivatives. In future the use of quantum computing, computational softwares and databases in modelling molecular interactions and predicting features and parameters needed for drug development, such as pharmacokinetic and pharmacodynamics, will result in few false positive leads in drug development. This review discusses plant-based natural product drug discovery and how innovative technologies play a role in next-generation drug discovery.

The re-emergence of natural products for drug discovery in the genomics era

Using Natural Products for Drug Discovery: the Impact of the Genomics Era

Recent advances in natural product discovery.

Targeting Bacterial Genomes for Natural Product Discovery

Natural products in drug discovery: advances and opportunities

Natural products as drug leads: exploring their potential in drug discovery and development

Genome Mining as New Challenge in Natural Products Discovery

NATURAL PRODUCTS: FROM TRADITIONAL MEDICINE TO LEAD COMPOUNDS FOR DRUG DEVELOPMENT IN THE 21ST CENTURY

The re-emerging role of microbial natural products in antibiotic discovery

Screening and identification of novel biologically active natural compounds

Recent advances in genome mining and synthetic biology for discovery and biosynthesis of natural products

Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery

Drug Discovery and Natural Products: End of an Era or an Endless Frontier?

Discovering new bioactive molecules from microbial sources

The pharmaceutical industry and natural products: historical status and new trends

Genome mining for the search and discovery of bioactive compounds: The Streptomyces paradigm

Virtual Screening on Natural Products for Discovering Active Compounds and Target Information

Unraveling the Molecular Targets of Natural Products: Insights from Genomic and Proteomic Analyses

Exploring nature's battlefield: organismic interactions in the discovery of bioactive natural products

Lead/Drug Discovery from Natural Resources

Recent advances in the culture-independent discovery of natural products using metagenomic approaches